Illustrative image – not actual.Shasun Pharmaceuticals is likely to begin commercial production at its proposed plant in Visakhapatnam, Andhra Pradesh, by June 2012.
The plant is estimated to cost Rs 100 crore will have an initial production capacity of 1,200 tonne of bulk drugs per annum. It will manufacture generic APIs (active pharmaceutical ingredients), particularly for the Japanese market. The company has raised $6 million (approx Rs 29.4 crore) through external commercial borrowings to fund the project. Also, it recently issued warrants worth Rs 15 crore.
Related Links:
Project profile
